The BIOTEK2021 programme is the Research Council of Norway’s most comprehensive research initiative in the field of biotechnology. The programme will run from 2012 through 2021.
The BIOTEK21 programme succeeds the Programme on Functional Genomics in Norway (FUGE), which was concluded in 2011.
An exciting new call which aims to ensure that cancer patients can benefit from promising biotechnological research sooner is now available. The announced funding shall be used to explore and develop the commercial potential of previously obtained research results.
This year's optimization announcement in biotechnology is now available on the Research Council website. It is announced 40 million kroner for projects related to marine agricultural- and industrial biotechnology.
The Research Council participates through the national program Biotechnology for Innovation (BIOTEK2021) in the first joint transnational call from ERACoSysMed, a new ERA-NET Cofund that focuses on promoting the implementation of systems medicine in clinical research and medical practice.